An experimental Johnson & Johnson vaccine completely prevented HIV infection in half of monkeys that got the shot and then were exposed to high doses of an aggressive virus, results that spurred the company to test the vaccine in people, academic and company researchers said on Thursday. The international trial is underway in 400 healthy volunteers in the United States, East Africa, South Africa and Thailand.